Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Do Off-Label Drug Practices Argue Against FDA Efficacy Requirements?

April 26, 2017argue array drug fda off-label practices requirements

0

Posted

Do Off-Label Drug Practices Argue Against FDA Efficacy Requirements?

1 Answer

0

Posted

Publisher InfoPaper provided by The Ratio Institute in its series Ratio Working Papers with number 28. Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF Length: 45 pages Date of creation: 20 Dec 2003 Date of revision: Handle: RePEc:hhs:ratioi:0028 Contact details of provider: Postal: The Ratio Institute, P.O. Box 5095, SE-102 42 Stockholm, Sweden Phone: 08-587 054 00 Fax: 08-587 054 05 Email: liame2(‘se’,’ratio’,’m7i7′,’info’) Web page: http://www.ratio.se/ More information through EDIRC For technical questions regarding this item, or to correct its listing, contact: liame2(‘se’,’ratio’,’m7i7′,’berggren’,’niclas’) (Niclas Berggren). Related researchKeywords: Food and Drug Administration; drug approval; efficacy requirements; off-label uses; on-label uses; certification; liberalization; Find related papers by JEL classification: I18 – Health, Education, and Welfare – – Health – – – Gov